LSV Asset Management Has $299.30 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

LSV Asset Management cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 4.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 931,574 shares of the company’s stock after selling 41,650 shares during the period. LSV Asset Management owned about 0.36% of HCA Healthcare worth $299,296,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Atlantic Edge Private Wealth Management LLC purchased a new position in HCA Healthcare in the fourth quarter valued at about $27,000. Bangor Savings Bank grew its stake in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare in the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $28,000. Finally, GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA traded down $9.77 during mid-day trading on Friday, reaching $387.98. The company had a trading volume of 2,248,803 shares, compared to its average volume of 1,129,325. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $403.05. The company has a market capitalization of $101.62 billion, a P/E ratio of 19.34, a P/E/G ratio of 1.52 and a beta of 1.67. The company’s 50-day moving average is $355.43 and its 200-day moving average is $336.01. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the previous year, the company posted $4.29 earnings per share. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 22.5 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is presently 13.16%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Barclays increased their price objective on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Robert W. Baird started coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price on the stock. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $359.89.

Check Out Our Latest Stock Analysis on HCA

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,844 shares of company stock worth $3,185,932. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.